ABSTRACT Objective Polycystic ovary syndrome (PCOS) is a recognized risk factor for nonalcoholic fatty liver disease (NAFLD). The aims of this study were to investigate the prevalence and factors associated with NAFLD in women with PCOS and evaluate noninvasive indices of hepatic fibrosis in patients with PCOS and NAFLD. Subjects and methods Patients with PCOS (n = 87) and women without PCOS (n = 40; controls) were included. NAFLD was diagnosed by abdominal ultrasonography after exclusion of alcohol consumption and viral or autoimmune liver disease. Anthropometric, clinical and metabolic variables, homeostasis model assessment of insulin resistance (HOMA-IR) index, lipid accumulation product (LAP), FIB-4 index, NAFLD score, and transient elastography (TE; FibroScan) were obtained in subsets of patients with PCOS and NAFLD. Results A total of 87 patients with PCOS were included (mean age: 34.4 ± 5.7 years, mean body mass index [BMI]: 34.7 ± 4.7 kg/m 2 ). NAFLD was present in 67 (77.0%) patients with PCOS versus 21 of 40 (52.5%) controls (p = 0.005). Women with PCOS and liver steatosis, compared with their NAFLD-free counterparts, had higher values of BMI, waist circumference, triglycerides, total cholesterol, alanine and aspartate aminotransferases, and γ-glutamyltransferase, along with higher frequencies of obesity, metabolic syndrome, and insulin resistance. NAFLD was independently associated with waist circumference, serum triglycerides, and alanine aminotransferase levels. The FIB-4 index was not compatible with advanced fibrosis in any of the evaluated patients, while NAFLD score and TE were compatible with advanced liver fibrosis in 1 of 26 (3.8%) and 3 of 25 (12%) patients, respectively. Conclusion Women with PCOS had a high risk of NAFLD, and a combination of both was associated with central obesity, dyslipidemia, insulin resistance, and metabolic syndrome. Noninvasive methods suggested low rates of severe hepatic fibrosis in Brazilian women with PCOS. Arch Endocrinol Metab. 2020;64(3):235-42

Objetivo A síndrome dos ovários policísticos (SOP) é o distúrbio endócrino mais comumemmulheres entre amenarca e a menopausa. O hiperandrogenismo clínico é o critério diagnóstico mais importante da síndrome, que se manifesta como hirsutismo em70% dos casos. Portadores de SOP hirsutas têmelevado risco cardiovascular. O Lipid accumulation product (LAP) é um índice para a avaliação da acumulação de lípidos nos adultos e é um preditor de risco cardiovascular. O objetivo deste estudo é avaliar a associação entre LAP e hirsutismo em portadoras da SOP. Métodos Estudo observacional transversal de banco de dados secundário, que incluiu 263 pacientes do Ambulatório de Hiperandrogenismo no período de novembro de 2009 a julho de 2014. Foram excluídas pacientes sem o índice de Ferriman-Gallwey e/ ou LAP. Foram utilizados como critérios diagnósticos da SOP os critérios de Rotterdam. Todas as pacientes foram submetidas à avaliação médica seguida da aferição e registro dos dados antropométricos e a realização dos seguintes exames laboratoriais: hormônio estimulante da tireoide (TSH), hormônio folículo estimulante (FSH), prolactina (PRL), Testosterona total, globulina ligadora dos hormônios sexuais (SHBG), 17-α- hidroxiprogesterona, (fase folicular), perfil lipídico, teste oral de tolerância à glicose, glico-hemoglobina a1C, insulina basal. Outras dosagens laboratoriais foram determinadas à critério clínico. O LAP e o HOMA-IR (homeostatic model assessment) foram calculados com os dados obtidos. As pacientes foram divididas em dois grupos: grupo das portadoras de SOP com LAP normal (LAp < 34,5) e grupo das portadoras de SOP com LAP alterado (LAP >34,5) para as comparações do hirsutismo. Para a análise estatística, foram utilizados os programas SPSS Statistics for Windows(r) e Microsoft Excel(r), sendo feitas análises descritivas (frequências, percentuais, médias, desviospadrão) e comparativas (t-Student e qui-quadrado). Foram consideradas relações significativas quando p-valor foi menor ou igual a 0,05. Resultados O LAP foi elevado na maioria das pacientes (n = 177; 67,3%) e o índice de Ferriman-Gallwey (IF) demonstrou que 58,5% das pacientes (n = 154) eram hirsutas. A análise por quartis de LAP, demonstrou correlação positiva (p = 0,04) entre pacientes comIF elevado e LAP no quartil superior (>79,5) quando comparadas àquelas com LAP menor que 29,0 (quartil inferior). Conclusão O estudo demonstrou associação do LAP elevado e hirsutismo. O escore de Ferriman-Gallwey poderia representar uma ferramenta simples e de baixo custo para inferir risco cardiovascular aumentado em portadoras da síndrome.

Objective Polycystic ovary syndrome (PCOS) is the most common endocrine metabolic disorder in women between menarche and menopause. Clinical hyperandrogenism is the most important diagnostic criterion of the syndrome, which manifests as hirsutism in 70% of cases. Hirsute carriers of PCOS have high cardiovascular risk. Lipid accumulation product (LAP) is an index for the evaluation of lipid accumulation in adults and the prediction of cardiovascular risk. The aim of this study was to evaluate the association between LAP and hirsutism in women with PCOS. Methods This was a cross-sectional observational study of a secondary database, which included 263 patients who had visited the Hyperandrogenism Outpatient Clinic from November 2009 to July 2014. The exclusion criteria were patients without Ferriman-Gallwey index (FGI) and/or LAP data. We used the Rotterdam criteria for the diagnosis of PCOS. All patients underwent medical assessment followed by measurement and recording of anthropometric data and the laboratory tests for measurement of the following: thyroid-stimulating hormone, follicle-stimulating hormone, prolactin, total testosterone, sex hormone binding globulin, 17-α-hydroxyprogesterone (follicular phase), glycohemoglobin A1c, and basal insulin. In addition, the subjects underwent lipid profiling and oral glucose tolerance tests. Other laboratory measurements were determined according to clinical criteria. LAP and the homeostatic model assessment index (HOMA-IR) were calculated using the data obtained. We divided patients into two groups: the PCOS group with normal LAP (< 34.5) and the PCOS group with altered LAP (> 34.5) to compare the occurrence of hirsutism. For statistical analysis, we used SPSS Statistics for Windows(r) and Microsoft Excel programs, with descriptive (frequencies, percentages, means, and standard deviations) and comparative analyses (Student's t-test and Chi-square test). We considered relations significant when the p-value was≤0.05. Results LAP was high in most patients (n = 177; 67.3%) and the FGI indicated that 58.5% of the patients (n = 154) had hirsutism. The analysis by LAP quartiles showed a positive correlation (p = 0.04) among patients with a high FGI and an upper quartile LAP (> 79.5) when compared with those with LAP < 29.0 (lower quartile). Conclusion This study demonstrated an association between high LAP and hirsutism. The FGI could represent a simple and low-cost tool to infer an increased cardiovascular risk in women with PCOS.

The present study aims at characterizing the nutritional status and food intake of patients with Polycystic Ovary Syndrome (PCOS). It is a cross-sectional study performed in patients with PCOStreated in secondary health care service by nutrition specialists.socio-demographic information, health profile, anthropometric measurements, biochemical and food intake data were obtained. The study included 54 women with an average age of 31.31 ±5.76 years: 63% were classified as obese at different levels; 74.1% presented cardiovascular risk according to waist-hip ratio, and 90.8% an increased waist circumference. Correlations between insulin resistance, measured by HOMA-IR index, and body mass index (r = 0.729, p = 0.028) were observed. Evaluation of nutritional intake revealed an insufficient amount of calories (73.6%), carbohydrates (54.7%), and micronutrients (calcium, 96.2%; iron, 98.1%). However 71.7% presented an excessive intake of lipids.There was no association between nutritional status, biochemical parameters and food intake (p> 0.05). PCOS patients present a high prevalence of obesity and nutritional inadequacies. Therefore, nutritional intervention strategies constitute important tools as a non-pharmacological treatment.

Este estudio buscó caracterizar el estado nutricional y consumo alimentario de las pacientes con Síndrome de Ovario Poliquístico (SOPQ). Se trata de un estudio transversal realizado con pacientes con SOPQ atendidas por el Equipo de Nutrición en servicios de atención secundaria de la salud. Se obtuvieron informaciones sociodemográficas y el perfil de salud, medidas antropométricas, datos bioquímicos y del consumo alimentario. En el estudio participaron 54 mujeres con edad promedio de 31,31± 5,76 años: 63% clasificadas con algún grado de obesidad; 74,1% con riesgo cardiovascular según la relación cintura-cadera y 90,8% con aumento de la circunferencia de cintura. Hubo correlación positiva entre la resistencia a la insulina, mensurada por el índice HOMA-IR, y el índice de masa corporal (r=0,729, p=0,028). Además, hubo elevada prevalencia de consumo insuficiente de calorías (73,6%), carbohidratos (54,7% y micronutrientes (calcio - 96,2%; hierro - 98.1%, en contraste con el 71,7% de ingesta excesiva de lípidos. No hubo asociación entre el estado nutricional, parámetros bioquímicos y consumo de alimentos (p>0,05). Pacientes diagnosticadas con SOPQ presentan una alta prevalencia de obesidad y deficiencias nutricionales. Por lo tanto, las medidas de intervención nutricional son herramientas importantes como parte del tratamiento no farmacológico.

O objetivo com esta pesquisa foi caracterizar o estado nutricional e o consumo alimentar de pacientes com síndrome de ovários policísticos (SOPC). Trata-se de estudo transversal realizado com portadoras de SOPC atendidas pela Equipe de Nutrição em serviço de atenção secundária à saúde. Foram obtidas informações sociodemográficas e perfil de saúde, medidas antropométricas, dados bioquímicos e do consumo alimentar. Participaram do estudo 54 mulheres, com média de 31,31± 5,76 anos, sendo 63% classificadas com algum grau de obesidade, 74,1% com risco cardiovascular segundo a razão cintura-quadril e 90,8% com circunferência de cintura aumentada. Houve correlação positiva entre a resistência insulina, mensurada pelo índice HOMA-IR, e índice de massa corporal (r=0,729; p=0,028). Além disso, houve elevada prevalência de consumo insuficiente de calorias (73,6%), carboidratos (54,7%) e micronutrientes (cálcio - 96,2%; ferro - 98,1%), contrastando com 71,7% de ingestão excessiva de lipídeos. Não houve associação entre estado nutricional, parâmetros bioquímicos e consumo alimentar (p>0,05). Concluiu-se que pacientes diagnosticadas com SOPC apresentam alta prevalência de obesidade e inadequações nutricionais, denotando importância de medidas de intervenção nutricional como parte do tratamento não farmacológico.